AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2016
Jan 4, 2016
35119_dirs_2016-01-04_e0025afb-8e3f-4812-880e-134725e38f7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2015-12-31
Reporting Person: Warusz Joseph Michael (VP of Finance/Acting CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | Option (Right to Buy) | $1.13 | A | 55000 | Acquired | 2025-12-30 | Common Stock (55000) | Direct |
Footnotes
F1: The stock option vested immediately as to 13,750 shares and vests as to the remainder at a rate of 6.25% of the total shares underlying the stock option on each three (3) month anniversary of December 31, 2015.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3